Friday, November 08, 2019 11:58:47 AM
From Clinicaltrials
The Primary endpoint is: Overall Survival (OS) [Time Frame: 5 years]
Overall survival is defined as the time (in months) from the date of randomization to the death date.
A secondary outcome:Progression-free survival (PFS) [Time Frame: 5 years]
Progression-free survival is defined as the time (in months) from the date of randomization until the date of the Investigator-assessed radiological disease progression or death due to any cause.
The talk around this preplanned interim efficacy review was the hazard ratio.
In the Celsion PR of Nov 4, 2019: The OPTIMA Study, like other oncology studies, is subject to tumor progression, and the timing of efficacy results is entirely event driven. We estimate that our next interim safety and efficacy analysis will occur during the second quarter of 2020.”
“The hazard ratio for success at 158 events is 0.70. This is below the hazard ratio of 0.65 observed for the 285 patients in the HEAT Study subgroup of patients treated with RFA > 45 minutes,” Mr. Tardugno added.
Edit: If the hazard ratio at 158 deaths is 0.70 or above, does that trigger the finding that the trial is a success?
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM